 |
Recombinant human luteinizing hormone |
|---|---|
| Trade Name | Luveris |
| Orphan Indication | For use in association with recombinant human follicle stimulating hormone for the treatment of women with chronic anovulation due to hypogonadotropic hypogonadism |
| USA Market Approval | USA |
| USA Designation Date | 1994-10-07 00:00:00 |
| Sponsor | EMD Serono, Inc.;One Technology Place;Rockland, Massachusetts, 02370 |
